U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C14H19N3S.3C4H4O4
Molecular Weight 870.988
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 3
Charge 0

SHOW SMILES / InChI
Structure of METHAPYRILENE FUMARATE

SMILES

OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.CN(C)CCN(CC3=CC=CS3)C4=CC=CC=N4

InChI

InChIKey=OLGIEIJNOQGBSS-VQYXCCSOSA-N
InChI=1S/2C14H19N3S.3C4H4O4/c2*1-16(2)9-10-17(12-13-6-5-11-18-13)14-7-3-4-8-15-14;3*5-3(6)1-2-4(7)8/h2*3-8,11H,9-10,12H2,1-2H3;3*1-2H,(H,5,6)(H,7,8)/b;;3*2-1+

HIDE SMILES / InChI

Molecular Formula C14H19N3S
Molecular Weight 261.386
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Methapyrilene is an antihistamine and anticholinergic of the pyridine chemical class which was developed in the early 1950s. It was sold under the trade names Co-Pyronil and Histadyl EC. It has relatively strong sedative effects, to the extent that its primary use was as a medication for insomnia rather than for its antihistamine action. Together with scopolamine, it was the main ingredient in Sominex, Nytol, and Sleep-Eze. It also provided the sedative component of Excedrin PM. Manufacturers voluntarily withdrew methapyrilineb drug products from the market in May and June 1979, when methapyrilene was demonstrated to cause liver cancer in rats when given chronically.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Doses

Doses

DosePopulationAdverse events​
2.5 g single, oral
Overdose
Dose: 2.5 g
Route: oral
Route: single
Dose: 2.5 g
Sources:
healthy, 19 years
Health Status: healthy
Age Group: 19 years
Sex: F
Sources:
Other AEs: Dizziness, Stomach cramps...
Other AEs:
Dizziness
Stomach cramps
Delusions
Sources:
25 mg single, intravenous
Dose: 25 mg
Route: intravenous
Route: single
Dose: 25 mg
Sources:
healthy, 20 - 35 years
Health Status: healthy
Age Group: 20 - 35 years
Sex: M+F
Sources:
50 mg single, oral
Dose: 50 mg
Route: oral
Route: single
Dose: 50 mg
Sources:
healthy, 20 - 35 years
Health Status: healthy
Age Group: 20 - 35 years
Sex: M+F
Sources:
AEs

AEs

AESignificanceDosePopulation
Delusions
2.5 g single, oral
Overdose
Dose: 2.5 g
Route: oral
Route: single
Dose: 2.5 g
Sources:
healthy, 19 years
Health Status: healthy
Age Group: 19 years
Sex: F
Sources:
Dizziness
2.5 g single, oral
Overdose
Dose: 2.5 g
Route: oral
Route: single
Dose: 2.5 g
Sources:
healthy, 19 years
Health Status: healthy
Age Group: 19 years
Sex: F
Sources:
Stomach cramps
2.5 g single, oral
Overdose
Dose: 2.5 g
Route: oral
Route: single
Dose: 2.5 g
Sources:
healthy, 19 years
Health Status: healthy
Age Group: 19 years
Sex: F
Sources:
PubMed

PubMed

TitleDatePubMed
Toxicology of vancomycin in laboratory animals.
1981 Nov-Dec
The carcinogenic effect of methapyrilene combined with nitrosodiethylamine given to rats in low doses.
1992 Jul
Effects of induction and inhibition of cytochromes P450 on the hepatotoxicity of methapyrilene.
1998 Nov
Principal component analysis of mass spectra of peptides generated from the tryptic digestion of protein mixtures.
2001
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles.
2001 Aug 15
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity.
2001 Mar 31
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.
2001 Sep
Morphological transformation of Syrian hamster embryo cells at pH 6.7 by bemitradine, a nongenotoxic carcinogen.
2001 Summer
Non-genotoxic carcinogens: early effects on gap junctions, cell proliferation and apoptosis in the rat.
2002 Dec 2
Cross-site comparison of gene expression data reveals high similarity.
2004 Mar
Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene.
2004 Mar
Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression.
2004 Mar
Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
2005 Aug 4
Tissue distribution of quetiapine in 20 cases in Virginia.
2006 May
Identification of genes implicated in methapyrilene-induced hepatotoxicity by comparing differential gene expression in target and nontarget tissue.
2007 Apr
Literature-based compound profiling: application to toxicogenomics.
2007 Nov
Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore.
2008 Aug
A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats.
2008 Aug 19
Primary rat hepatocytes as in vitro system for gene expression studies: comparison of sandwich, Matrigel and 2D cultures.
2008 Dec
Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
2010 Dec
Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.
2011 Nov
Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens.
2012 Aug
Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
2012 Sep
Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes.
2013 Feb
Disruption of spindle checkpoint function ahead of facilitation of cell proliferation by repeated administration of hepatocarcinogens in rats.
2015 Dec
Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure.
2015 Dec 1
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Methapyrilene failed to induce formation of DNA adducts in L5178Y cell DNA at doses which induced mutations at the thymidine kinase locus. These data suggest that methapyrilene induces mutations in this system through an indirect genotoxic mechanism; e.g., via an oxidative mechanism or interaction with chromosomal proteins.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:01:18 GMT 2023
Edited
by admin
on Fri Dec 15 15:01:18 GMT 2023
Record UNII
KJ5I25TXYL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
METHAPYRILENE FUMARATE
MI   USP-RS   WHO-DD  
Common Name English
METHAPYRILENE FUMARATE [MI]
Common Name English
1,2-ETHANEDIAMINE, N,N-DIMETHYL-N'-2-PYRIDINYL-N'-(2-THIENYLMETHYL)-, (E)-2-BUTENEDIOATE (2:3)
Common Name English
Methapyrilene fumarate [WHO-DD]
Common Name English
THENYLPYRAMINE FUMARATE
Systematic Name English
2-[[2-(Dimethylamino)ethyl]-2-thenylamino]pyridine fumarate (2:3)
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29578
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
Code System Code Type Description
CAS
33032-12-1
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
EVMPD
SUB14535MIG
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
NCI_THESAURUS
C83953
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
FDA UNII
KJ5I25TXYL
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
MERCK INDEX
m7301
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY Merck Index
SMS_ID
100000076549
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
ECHA (EC/EINECS)
251-351-3
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
ChEMBL
CHEMBL1411979
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
EPA CompTox
DTXSID0047404
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
PUBCHEM
6436730
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
DRUG BANK
DBSALT002793
Created by admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY